Advanced cancer
Blog
Our series of blog posts
Our blogs are written by health professionals who have expertise in the field of prostate and prostate cancer. You can therefore be assured that the information provided is precise and accurate. The many topics covered are intended to help people better understand the effects of the disease, treatment options and how to improve their quality of life.
My Journey with an Advanced Prostate Cancer: What Is Counting for Me
Prostate cancer highly affects the quality of life of those who suffer from it, mainly at an advanced stage.
Xofigo®: Quebec patients have access to a new treatment for prostate cancer
Men in Quebec are one step closer to accessing Xofigo, for the treatment of castration-resistant prostate cancer with symptomatic bone metastases and no known visceral metastatic disease, thanks to a recent announcement by the Quebec government.
Health Canada Approves New Indication for Castration-Resistant Prostate Cancer
New Indication for the Use of Xtandi® (enzalutamide) Capsules Approval based on improved overall survival, delayed time to radiographic progression and an overall positive risk-benefit profile In the Phase III PREVAIL trial, men receiving enzalutamide therapy exhibited a statistically significant improvement in both overall survival and delayed time to radiographic progression or death as compared to […]
Two-drug combination may improve survival in men with advanced cancer
Treating men with advanced prostate cancer using a two-drug combination may significantly increase survival. Indeed, a Harvard-affiliated medical research team found that patients with advanced prostate cancer treated with a combination of ADT and a chemotherapy drug called docetaxel lived approximately 14-17 months longer than men who started their treatment on ADT alone. These results […]
ZYTIGA® – Now Reimbursed in Quebec
ZYTIGA®* Now Reimbursed in Québec for Use Prior to Chemotherapy In Men with Metastatic Prostate Cancer. Men with metastatic castration-resistant prostate cancer (mCRPC) in Québec now have access to a therapy that can be used prior to chemotherapy. Effective February 3, 2014, the province has added ZYTIGA® (abiraterone acetate) to the public drug formulary for the […]